Literature DB >> 11981762

Effects of Sho-Saiko-to on hepatocarcinogenesis and 8-hydroxy-2'-deoxyguanosine formation.

Goshi Shiota1, Yoshiko Maeta, Tomoyuki Mukoyama, Atsushi Yanagidani, Akihide Udagawa, Kenji Oyama, Kazuo Yashima, Yosuke Kishimoto, Yoichiro Nakai, Tetsuo Miura, Hisao Ito, Yoshikazu Murawaki, Hironaka Kawasaki.   

Abstract

Oxidative stress plays an important role in hepatocarcinogenesis. Although Sho-saiko-to (TJ-9), a Japanese herbal medicine which has been recently administered to patients with chronic liver disease in Japan, prevents hepatocarcinogenesis, the mechanism by which TJ-9 protects against cancer development is not fully understood. 8-Hydroxy-2'-deoxyguanosine (8-OHdG), a DNA adduct by reactive oxygen species, is known as a parameter of genetic risk for hepatocarcinogenesis. To clarify whether the preventive effect on hepatocarcinogenesis by TJ-9 is dependent on 8-OHdG, the effect on 8-OHdG levels by TJ-9 was examined by using high-performance liquid chromatography-mass spectrometry (LC-MS) in a diethylnitrosamine (DEN)-induced hepatocarcinogenesis model of male Fisher rats. TJ-9 reduced the number of preneoplastic cells, detected as the glutathione S transferase P (GST-P)-positive hepatocytes, and inhibited the development of liver tumors. TJ-9 also significantly decreased the formation of 8-OHdG, as indicated by LC-MS and immunohistochemical analysis. In addition, ornithine decarboxylase (ODC) activity and the number of proliferating cell nuclear antigen (PCNA)-positive cells were not altered. An electron paramagnetic resonance spin-trapping technique showed that TJ-9 scavenges hydroxyl radicals in a dose-dependent manner. In conclusion, the results of the present study suggest that TJ-9 prevents hepatocarcinogenesis in association with inhibition of 8-OHdG formation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11981762     DOI: 10.1053/jhep.2002.33066

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  14 in total

Review 1.  Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy.

Authors:  Koji Miyanishi; Toshifumi Hoki; Shingo Tanaka; Junji Kato
Journal:  World J Hepatol       Date:  2015-03-27

Review 2.  Prevalence and current therapy in chronic liver disorders.

Authors:  Muhammad Daniyal; Muhammad Akram; Rida Zainab; Naveed Munir; Aamir Sharif; Syed Muhammad Ali Shah; Bin Liu; Wei Wang
Journal:  Inflammopharmacology       Date:  2019-02-08       Impact factor: 4.473

3.  Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.

Authors:  Masao Omata; Laurentius A Lesmana; Ryosuke Tateishi; Pei-Jer Chen; Shi-Ming Lin; Haruhiko Yoshida; Masatoshi Kudo; Jeong Min Lee; Byung Ihn Choi; Ronnie T P Poon; Shuichiro Shiina; Ann Lii Cheng; Ji-Dong Jia; Shuntaro Obi; Kwang Hyub Han; Wasim Jafri; Pierce Chow; Seng Gee Lim; Yogesh K Chawla; Unggul Budihusodo; Rino A Gani; C Rinaldi Lesmana; Terawan Agus Putranto; Yun Fan Liaw; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2010-03-18       Impact factor: 6.047

4.  Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell-induced oxidative stress.

Authors:  Masato Tsuchiya; Hiroshi Kono; Masanori Matsuda; Hideki Fujii; Ivan Rusyn
Journal:  Int J Cancer       Date:  2008-12-01       Impact factor: 7.396

5.  Total cholesterol, alanine aminotransferase and the risk of primary liver cancer: A population-based prospective study.

Authors:  Miaomiao Sun; Wanchao Wang; Xining Liu; Yiming Wang; Haozhe Cui; Siqing Liu; Liying Cao
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

6.  Renal protective effect of xiao-chai-hu-tang on diabetic nephropathy of type 1-diabetic mice.

Authors:  Chun-Ching Lin; Liang-Tzung Lin; Ming-Hong Yen; Juei-Tang Cheng; Chung-Hsi Hsing; Ching-Hua Yeh
Journal:  Evid Based Complement Alternat Med       Date:  2012-03-07       Impact factor: 2.629

7.  Anti-inflammatory drugs reduce the risk of hepatocellular carcinoma development.

Authors:  Yasushi Rino; Kazuo Tarao
Journal:  ISRN Oncol       Date:  2011-07-07

8.  Herbal medicine and hepatocellular carcinoma: applications and challenges.

Authors:  Yan Li; Robert C G Martin
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-20       Impact factor: 2.629

9.  Evaluation of oral subchronic toxicity of soshiho-tang water extract: the traditional herbal formula in rats.

Authors:  Mee-Young Lee; Chang-Seob Seo; In-Shik Shin; Young-Bum Kim; Jung-Hoon Kim; Hyeun-Kyoo Shin
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-20       Impact factor: 2.629

10.  Subacute toxicity and stability of Soshiho-tang, a traditional herbal formula, in Sprague-Dawley rats.

Authors:  In Sik Shin; Mee Young Lee; Yongbum Kim; Chang Seob Seo; Jung Hun Kim; Hyeun Kyoo Shin
Journal:  BMC Complement Altern Med       Date:  2012-12-27       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.